Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.01

-0.4%

Nov 19 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (19418)	4/22/1998 10:14:00 PM
From: John O'Neill	Read Replies (1) of 32384

Henry..sorry about the SERM/rexinoid confusion I'm having. The time line pipeline had LGND down as the partner for Targretin for CA & LLY as diabetes and metabolic disease..that's what confused me. Would you mind once again discussing what LGND gets for giving LLY exclusive rights for use or Targretin for breast CA and how Targretin would compare as a tx in it's own right. IE How much money can LGND expect to make if Targretin is found to be very valuable as an adjunct drug to Evista. Thanks JO (take 90 % right as a complement)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next